UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes.
Puerarin has multiple pharmacological effects and is widely prescribed for patients with cardiovascular diseases, including hypertension, cerebral ischemia, myocardial ischemia, diabetes mellitus, and arteriosclerosis. While puerarin is a useful therapeutic agent, its mechanisms of action have not been well defined. Understanding puerarin metabolism, in particular its interactions with metabolizing enzymes, will contribute to our understanding of its toxic and therapeutic effects and may help to elucidate potential negative drug-drug interactions. In this study, the major metabolite of puerarin was obtained from the urine of rats administered puerarin, by a semi-preparative high-performance liquid chromatography method. The major metabolite was identified as puerarin-7-O-glucuronide. In vitro, we used a UDP-glucuronosyltransferase (UGT) reaction screening method with 12 recombinant human UGTs to demonstrate that formation of puerarin-7-O-glucuronide was catalyzed by UGT1A1, 1A9, 1A10, 1A3, 1A6, 1A7, and 1A8. UGT1A1, 1A9, and 1A10 significantly catalyzed puerarin-7-O-glucuronide formation, and the activity of UGT1A1 was significantly higher than those of 1A9 and 1A10. The V                 (max) of UGT1A1 was two- to threefold higher than the levels of UGT1A9 or 1A10, with a lower K                 (                   m                 ) value and a higher V                 (max)/K                 (                   m                 ) value. The kinetics of puerarin-7-O-glucuronide formation catalyzed by UGT1A1 were similar to those of the pooled human liver microsomes (HLMs), with V                 (max) values of 186.3 and 149.2 pmol/min/mg protein, and K                 (                   m                 ) values of 811.3 and 838.9 μM, respectively. Furthermore, bilirubin and β-estradiol, probe substrates for UGT1A1, significantly inhibited the formation of puerarin-7-O-glucuronide in HLMs.
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Cardiovascular Disease, 250 Changgangdong Road, Guangzhou, China.
Cheng-Feng
CF
Luo
Bin
B
Cai
Ning
N
Hou
Mu
M
Yuan
Shi-Ming
SM
Liu
Hong
H
Ji
Long-Gen
LG
Xiong
Wei
W
Xiong
Jian-Dong
JD
Luo
Min-Sheng
MS
Chen
D000818:Animals; D001663:Bilirubin / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism; D005260:Female; D020719:Glucuronides / Q000378:metabolism; D014453:Glucuronosyltransferase / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007529:Isoflavones / Q000378:metabolism / Q000493:pharmacokinetics* / Q000652:urine; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D000090264:UDP-Glucuronosyltransferase 1A9; D000099148:UGT1A1 Enzyme
D001663:Bilirubin; D004958:Estradiol; D020719:Glucuronides; D014453:Glucuronosyltransferase; D007529:Isoflavones; D011994:Recombinant Proteins; D000090264:UDP-Glucuronosyltransferase 1A9; D000099148:UGT1A1 Enzyme; C000715591:UGT1A9 protein, human; C580761:puerarin-7-O-glucuronide; C122075:UDP-glucuronosyltransferase, UGT1A3; C110655:UDP-glucuronosyltransferase, UGT1A6; C476725:bilirubin uridine-diphosphoglucuronosyl transferase 1A10; C033607:puerarin